According to Kymera Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.15 B. In 2022 the company made an earning of -$0.16 B a decrease over its 2021 earnings that were of -$0.11 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.15 B | -5.09% |
2022 | -$0.16 B | 54.56% |
2021 | -$0.11 B | 119.98% |
2020 | -$45.48 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -24.52% | ๐บ๐ธ USA |